The abstract is read at the publisher; the summary is JClub's.
Cherry angiomas are more frequent in people with neurofibromatosis type 1 than in controls (48% vs 18%; odds ratio 4.26), with earlier onset in NF1.
- Why it matters: Vascular skin findings in NF1 are incompletely characterized, and the prevalence plus underlying biology of cherry angiomas were unknown.
- What they did: In a French prospective comparative cross-sectional study (Oct 2020–Mar 2021), researchers assessed CA prevalence and performed histopathologic, genomic, and cell-specific molecular analyses on NF1-associated CAs and control samples.
- The result: Somatic NF1 loss-of-function second hits occurred in 26 of 39 NF1-associated CAs (67%) and none in controls, with co-occurring activating variants (most often in GNAQ) and increased phosphoextracellular signal-regulated kinase signaling in endothelial cells and telocytes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.